Form 4: BioLife Solutions Officer Sells Shares to Cover Tax Obligations

Karen A. Foster, Chief Quality and Operations Officer of BioLife Solutions, sold 277 shares of common stock on October 30, 2024, to cover tax withholding obligations related to vesting restricted stock.

Summary

• On October 30, 2024, Karen A. Foster, Chief Quality and Operations Officer of BioLife Solutions Inc. (BLFS), sold 277 shares of common stock.
• The sale was executed at a price of $23.15 per share.
• The transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted by Foster on January 3, 2023.
• The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
• Following the transaction, Foster directly owns 157,291 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily reflect a change in the officer's confidence in the company.

Industry Context

This is a routine Form 4 filing, indicating an insider transaction. Such filings are common and provide transparency into the trading activities of company executives. The use of a 10b5-1 plan suggests the insider planned the transaction in advance.

Stakeholder Impact

• The sale of shares by an officer could have a minor psychological impact on shareholders, but the pre-planned nature of the sale mitigates any significant concern.

Key Dates